SCHEMBL17127330

SCHEMBL17127330

CCCOc1ccc2cc(Oc3ccc(C(=O)C(SCCOCC)C(C)(C)C)c4ccccc34)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 4/20 0.41
▸ CNR2 P34972 4/20 0.41
▸ CYP2C9 P11712 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ CYSLTR2 Q9NS75 2/20 0.34
▸ CYSLTR1 Q9Y271 2/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ PNLIP P16233 1/20 0.33
▸ FFAR1 O14842 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ PARG Q86W56 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ PPARG P37231 1/20 0.32
▸ PPARD Q03181 1/20 0.32
▸ PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17127331 0.95 CNR2 (0.42) CNR1CNR2CYP2C9CYSLTR2CYSLTR1
SCHEMBL17126861 0.94 CNR1 (0.39) CNR1CNR2CYP2C9NPC1RAB9A
SCHEMBL17126858 0.93 CNR1 (0.41) CNR1CNR2CYP2C9PDE10APNLIP
SCHEMBL17126865 0.91 CNR1 (0.41) CNR1CNR2CYP2C9PDE10APNLIP
SCHEMBL17127328 0.91 CDC25B (0.37) CNR1CNR2FFAR1KDM4EALDH1A1
SCHEMBL17127352 0.86 FFAR1 (0.39) CNR1CNR2CYP2C9FFAR1KDM4E
SCHEMBL17126857 0.82 APP (0.36) NPC1RAB9AFFAR1KDM4ELMNA
SCHEMBL17126863 0.81 ACACB (0.37) LMNAMAPTSMN1; SMN2
SCHEMBL17127022 0.77 PTGS2 (0.38) CYP2C9NPC1RAB9AKDM4EALDH1A1
SCHEMBL17126856 0.77 SMN1; SMN2 (0.33) LMNAMAPTPPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS CNR1 4336/4885CNR2 4651/4885CYP2C9 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback